TLRY: Tilray, Inc. Stock

by  •  • Comments Off on TLRY: Tilray, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 4,184.02
Enterprise Value ($M) 4,616.08
Book Value ($M) 373.90
Book Value / Share 2.18
Price / Book 12.85
NCAV ($M) -225.03
NCAV / Share -1.31
Price / NCAV -21.36

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 1.40
Current Ratio 1.91

Balance Sheet (mrq) ($M)
Current Assets 347.02
Assets 945.95
Liabilities 572.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -201.12
Net Income -271.07
Earnings Per Share Basic And Diluted -2.15

Cash Flow Statement (mra) ($M)
Cash From Operations -129.35
Cash from Investing -41.68
Cash from Financing -41.68

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13D/A Kennedy Brendan 7.90 -6.74
02-16 13D/A Groh Christian 2.23 -44.93
02-16 13D/A Blue Michael G. 12.00 -46.74
02-16 13G/A Etf Managers Group, Llc 4.08 -18.60
02-16 13G/A CVI Investments, Inc. 4.90 -30.46

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-02-19 10-K Annual Report – 10-K
2020-11-09 10-Q Quarterly Report – 10-Q
2020-08-10 10-Q Quarterly Report – 10-Q
2020-05-11 10-Q Quarterly Report – 10-Q1-2020
2020-04-29 10-K/A Annual Report – 10-K/A
2020-03-02 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-02-26 2,590,329 19,342,300 13.39
2021-02-25 6,384,288 29,757,000 21.45
2021-02-24 6,325,565 25,806,600 24.51
2021-02-23 4,858,783 27,378,300 17.75

(click for more detail)

(click for list of largest short owners)

Similar Companies
TGTX – TG Therapeutics, Inc. THTX – Theratechnologies Inc.
TLGT – Teligent, Inc. TLSA – Tiziana Life Sciences plc American Depository Share
TNXP – Tonix Pharmaceuticals Holding Corp.


Financial data and stock pages provided by
Fintel.io